Novartis burnishes prospects for its big asthma drug with positive PhIII data from a similar treatment - Endpoints News https://t.co/CUhyxtStKI — IDRO (@IDROOhio) May 31, 2019
Novartis burnishes prospects for its big asthma drug with positive PhIII data from a similar treatment - Endpoints News https://t.co/CUhyxtStKI
No comments:
Post a Comment